Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.

German CA, Shapiro MD.

BioDrugs. 2019 Nov 28. doi: 10.1007/s40259-019-00399-6. [Epub ahead of print]

PMID:
31782112
2.

Age is just a Number (but which one is it?).

Mehta A, Shapiro MD.

Eur Heart J Cardiovasc Imaging. 2019 Nov 20. pii: jez288. doi: 10.1093/ehjci/jez288. [Epub ahead of print] No abstract available.

PMID:
31746979
3.

Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.

Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S.

J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942. doi: 10.1016/j.jacc.2019.08.1016. Review.

PMID:
31601373
4.

Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.

Duell PB, Gidding SS, Andersen RL, Knickelbine T, Anderson L, Gianos E, Shrader P, Kindt I, O'Brien EC, McCann D, Hemphill LC, Ahmed CD, Martin SS, Larry JA, Ahmad ZS, Kullo IJ, Underberg JA, Guyton J, Thompson P, Wilemon K, Roe MT, Rader DJ, Cuchel M, Linton MF, Shapiro MD, Moriarty PM, Knowles JW.

Atherosclerosis. 2019 Oct;289:85-93. doi: 10.1016/j.atherosclerosis.2019.08.007. Epub 2019 Aug 19.

5.

Bridging the Gap Between Cardiology and Family Medicine.

Wójcik C, Shapiro MD.

Circulation. 2019 Aug 27;140(9):709-711. doi: 10.1161/CIRCULATIONAHA.119.040151. Epub 2019 Aug 26. No abstract available.

PMID:
31449452
6.

The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.

Warden BA, Shapiro MD, Fazio S.

Ann Pharmacother. 2019 Dec;53(12):1214-1219. doi: 10.1177/1060028019864669. Epub 2019 Jul 25.

PMID:
31342786
7.

Pigeon foot feathering reveals conserved limb identity networks.

Boer EF, Van Hollebeke HF, Park S, Infante CR, Menke DB, Shapiro MD.

Dev Biol. 2019 Oct 15;454(2):128-144. doi: 10.1016/j.ydbio.2019.06.015. Epub 2019 Jun 24.

8.

Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.

Mahmood T, Shapiro MD.

Curr Opin Cardiol. 2019 Sep;34(5):519-525. doi: 10.1097/HCO.0000000000000657.

PMID:
31246589
9.

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.

Wójcik C, Shapiro MD.

J Fam Pract. 2019 May;68(4):206;210;212;214;217;221B.

PMID:
31226173
10.

Rapid experimental evolution of reproductive isolation from a single natural population.

Villa SM, Altuna JC, Ruff JS, Beach AB, Mulvey LI, Poole EJ, Campbell HE, Johnson KP, Shapiro MD, Bush SE, Clayton DH.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13440-13445. doi: 10.1073/pnas.1901247116. Epub 2019 Jun 10.

11.

Aspirin for Primary Prevention of Cardiovascular Disease.

Kheiri B, Barbarawi M, Bachuwa G, Shapiro MD.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005846. doi: 10.1161/CIRCOUTCOMES.119.005846. Epub 2019 Jun 5. No abstract available.

PMID:
31163982
12.

The PCSK9 revolution: Current status, controversies, and future directions.

Warden BA, Fazio S, Shapiro MD.

Trends Cardiovasc Med. 2019 May 21. pii: S1050-1738(19)30072-6. doi: 10.1016/j.tcm.2019.05.007. [Epub ahead of print] Review.

13.

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.

Warden BA, Minnier J, Watts GF, Fazio S, Shapiro MD.

J Clin Lipidol. 2019 Jul - Aug;13(4):580-585. doi: 10.1016/j.jacl.2019.04.008. Epub 2019 Apr 26.

PMID:
31130489
14.

Host defense triggers rapid adaptive radiation in experimentally evolving parasites.

Bush SE, Villa SM, Altuna JC, Johnson KP, Shapiro MD, Clayton DH.

Evol Lett. 2019 Mar 5;3(2):120-128. doi: 10.1002/evl3.104. eCollection 2019 Apr.

15.

Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials.

Wong ND, Shapiro MD.

Front Cardiovasc Med. 2019 Mar 6;6:14. doi: 10.3389/fcvm.2019.00014. eCollection 2019. Review.

16.

A four-questions perspective on public information use in sticklebacks (Gasterosteidae).

Webster MM, Chouinard-Thuly L, Herczeg G, Kitano J, Riley R, Rogers S, Shapiro MD, Shikano T, Laland KN.

R Soc Open Sci. 2019 Feb 20;6(2):181735. doi: 10.1098/rsos.181735. eCollection 2019 Feb.

17.

Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.

Shapiro MD, Minnier J, Tavori H, Kassahun H, Flower A, Somaratne R, Fazio S.

J Am Heart Assoc. 2019 Feb 19;8(4):e010932. doi: 10.1161/JAHA.118.010932.

18.

Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?

Kaufman TM, Fazio S, Shapiro MD.

Ann Intern Med. 2019 Jan 15;170(2):119-120. doi: 10.7326/M18-3009. Epub 2019 Jan 8. No abstract available.

PMID:
30615780
19.

Application of PCSK9 Inhibitors in Practice.

Kaufman TM, Warden BA, Minnier J, Miles JR, Duell PB, Purnell JQ, Wojcik C, Fazio S, Shapiro MD.

Circ Res. 2019 Jan 4;124(1):32-37. doi: 10.1161/CIRCRESAHA.118.314191.

PMID:
30605414
20.

The Intersection of Diabetes and Cardiovascular Disease-A Focus on New Therapies.

Dhindsa DS, Sandesara PB, Shapiro MD.

Front Cardiovasc Med. 2018 Nov 13;5:160. doi: 10.3389/fcvm.2018.00160. eCollection 2018. Review.

21.

Reclassifying Risk in Familial Hypercholesterolemia: The Power of a Coronary Artery Calcium Score of Zero.

Shapiro MD, Blankstein R.

JACC Cardiovasc Imaging. 2019 Sep;12(9):1805-1807. doi: 10.1016/j.jcmg.2018.10.010. Epub 2018 Nov 15. No abstract available.

PMID:
30448142
22.

"Taking a look under the hood"-imaging the phenotypic heterogeneity of familial hypercholesterolemia.

Shapiro MD, Fazio S.

J Clin Lipidol. 2018 Sep - Oct;12(5):1095-1098. doi: 10.1016/j.jacl.2018.05.020. Epub 2018 Jun 8. No abstract available.

PMID:
30318061
23.

The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Sandesara PB, Virani SS, Fazio S, Shapiro MD.

Endocr Rev. 2019 Apr 1;40(2):537-557. doi: 10.1210/er.2018-00184. Review.

PMID:
30312399
24.

Biologic bases of residual risk of cardiovascular events: A flawed concept.

Shapiro MD, Fazio S.

Eur J Prev Cardiol. 2018 Nov;25(17):1831-1835. doi: 10.1177/2047487318798060. Epub 2018 Sep 10. No abstract available.

PMID:
30196721
25.

Introgression of regulatory alleles and a missense coding mutation drive plumage pattern diversity in the rock pigeon.

Vickrey AI, Bruders R, Kronenberg Z, Mackey E, Bohlender RJ, Maclary ET, Maynez R, Osborne EJ, Johnson KP, Huff CD, Yandell M, Shapiro MD.

Elife. 2018 Jul 17;7. pii: e34803. doi: 10.7554/eLife.34803.

26.

Medication-based versus target-based lipid management.

Fazio S, Shapiro MD.

J Diabetes. 2018 Oct;10(10):789-792. doi: 10.1111/1753-0407.12789. Epub 2018 Jul 2. No abstract available.

PMID:
29962061
27.

Withdrawn: "Taking a look under the hood"-Imaging the phenotypic heterogeneity of familial hypercholesterolemia.

Shapiro MD, Fazio S.

J Clin Lipidol. 2018 May 30. pii: S1933-2874(18)30248-4. doi: 10.1016/j.jacl.2018.05.019. [Epub ahead of print]

PMID:
29935932
28.

PCSK9: From Basic Science Discoveries to Clinical Trials.

Shapiro MD, Tavori H, Fazio S.

Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227. Review.

29.

PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!

Shapiro MD, Fazio S.

Endocr Pract. 2018 May;24(5):495-497. doi: 10.4158/EP-2018-0121. Epub 2018 Apr 24. No abstract available.

PMID:
29688766
30.

Improved Genome Assembly and Annotation for the Rock Pigeon (Columba livia).

Holt C, Campbell M, Keays DA, Edelman N, Kapusta A, Maclary E, T Domyan E, Suh A, Warren WC, Yandell M, Gilbert MTP, Shapiro MD.

G3 (Bethesda). 2018 May 4;8(5):1391-1398. doi: 10.1534/g3.117.300443.

31.

Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.

Shapiro MD, Miles J, Tavori H, Fazio S.

Ann Intern Med. 2018 Mar 6;168(5):376-379. doi: 10.7326/M17-2485. Epub 2017 Nov 28. No abstract available.

PMID:
29181527
32.

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS.

Atherosclerosis. 2017 Dec;267:19-26. doi: 10.1016/j.atherosclerosis.2017.10.006. Epub 2017 Oct 6.

PMID:
29080546
33.

Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America.

Ladapo JA, Coles A, Dolor RJ, Mark DB, Cooper L, Lee KL, Goldberg J, Shapiro MD, Hoffmann U, Douglas PS.

BMJ Open. 2017 Sep 29;7(9):e016364. doi: 10.1136/bmjopen-2017-016364.

34.

Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities.

Kaufman TM, Duell PB, Purnell JQ, Wójcik C, Fazio S, Shapiro MD.

Circ Res. 2017 Aug 18;121(5):499-501. doi: 10.1161/CIRCRESAHA.117.311532. Review. No abstract available.

PMID:
28819040
35.

Risk Factors for Mortality Among Individuals With Peripheral Arterial Disease.

Amrock SM, Abraham CZ, Jung E, Morris PB, Shapiro MD.

Am J Cardiol. 2017 Sep 1;120(5):862-867. doi: 10.1016/j.amjcard.2017.05.057. Epub 2017 Jun 15.

PMID:
28734461
36.

Setting the Agenda for Preventive Cardiology.

Shapiro MD, Fazio S.

Circ Res. 2017 Jul 21;121(3):211-213. doi: 10.1161/CIRCRESAHA.117.311390. Review. No abstract available.

PMID:
28729452
37.

Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

Fazio S, Minnier J, Shapiro MD, Tsimikas S, Tarugi P, Averna MR, Arca M, Tavori H.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3340-3348. doi: 10.1210/jc.2016-4043.

38.

Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.

Edmiston JB, Brooks N, Tavori H, Minnier J, Duell B, Purnell JQ, Kaufman T, Wojcik C, Voros S, Fazio S, Shapiro MD.

J Clin Lipidol. 2017 May - Jun;11(3):667-673. doi: 10.1016/j.jacl.2017.03.001. Epub 2017 Mar 9.

PMID:
28506388
39.

"Mutation-negative" familial hypercholesterolemia-When negative is positive.

Shapiro MD.

J Clin Lipidol. 2017 Mar - Apr;11(2):325-327. doi: 10.1016/j.jacl.2017.01.015. Epub 2017 Feb 6. No abstract available.

PMID:
28502487
40.

Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.

Shapiro MD, Fazio S.

Nat Rev Cardiol. 2017 Jun;14(6):319-320. doi: 10.1038/nrcardio.2017.66. Epub 2017 May 4. No abstract available.

PMID:
28470176
41.

Normative Data for a Comprehensive Neuropsychological Test Battery used in the Assessment of Sports-Related Concussion.

Merritt VC, Meyer JE, Cadden MH, Roman CA, Ukueberuwa DM, Shapiro MD, Arnett PA.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):168-183. doi: 10.1093/arclin/acw090.

PMID:
28365744
42.

Genomic determinants of epidermal appendage patterning and structure in domestic birds.

Boer EF, Van Hollebeke HF, Shapiro MD.

Dev Biol. 2017 Sep 15;429(2):409-419. doi: 10.1016/j.ydbio.2017.03.022. Epub 2017 Mar 24.

43.

PCSK9 and Atherosclerosis - Lipids and Beyond.

Shapiro MD, Fazio S.

J Atheroscler Thromb. 2017 May 1;24(5):462-472. doi: 10.5551/jat.RV17003. Epub 2017 Mar 9. Review.

44.

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.

Shapiro MD, Fazio S.

F1000Res. 2017 Feb 13;6:134. doi: 10.12688/f1000research.9845.1. eCollection 2017. Review.

45.

Phylogenomics using Target-Restricted Assembly Resolves Intrageneric Relationships of Parasitic Lice (Phthiraptera: Columbicola).

Boyd BM, Allen JM, Nguyen NP, Sweet AD, Warnow T, Shapiro MD, Villa SM, Bush SE, Clayton DH, Johnson KP.

Syst Biol. 2017 Nov 1;66(6):896-911. doi: 10.1093/sysbio/syx027.

46.

Pigeonetics takes flight: Evolution, development, and genetics of intraspecific variation.

Domyan ET, Shapiro MD.

Dev Biol. 2017 Jul 15;427(2):241-250. doi: 10.1016/j.ydbio.2016.11.008. Epub 2016 Nov 12. Review.

47.

TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.

Handelsman Y, Shapiro MD.

Endocr Pract. 2017 Jan;23(1):100-112. doi: 10.4158/EP161445.RA. Epub 2016 Nov 7. Review.

PMID:
27819772
48.

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Ahmad ZS, Andersen RL, Andersen LH, O'Brien EC, Kindt I, Shrader P, Vasandani C, Newman CB, deGoma EM, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Kullo IJ, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW.

J Clin Lipidol. 2016 Sep-Oct;10(5):1223-9. doi: 10.1016/j.jacl.2016.07.011. Epub 2016 Aug 6.

49.

Applications of Advanced Imaging in Cardiac Electrophysiology.

Yadava M, Shapiro MD.

Curr Treat Options Cardiovasc Med. 2016 Nov;18(11):66. doi: 10.1007/s11936-016-0491-5. Review.

PMID:
27646314
50.

PCSK9 Association With Lipoprotein(a).

Tavori H, Christian D, Minnier J, Plubell D, Shapiro MD, Yeang C, Giunzioni I, Croyal M, Duell PB, Lambert G, Tsimikas S, Fazio S.

Circ Res. 2016 Jun 24;119(1):29-35. doi: 10.1161/CIRCRESAHA.116.308811. Epub 2016 Apr 27.

Supplemental Content

Loading ...
Support Center